Joshua Warolin
Pediatrics · Madera, CANPI 1356591200
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 25.2% of the total. Among pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $24.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$775
- Sanofi$344
- UCB, Inc.$156
- Rhythm Pharmaceuticals, Inc.$155
- Novo Nordisk$154
- Regeneron Healthcare Solutions, Inc.$145
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,05699%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $775 |
| Sanofi | 9 | $344 |
| UCB, Inc. | 7 | $156 |
| Rhythm Pharmaceuticals, Inc. | 6 | $155 |
| Novo Nordisk | 7 | $154 |
| Regeneron Healthcare Solutions, Inc. | 5 | $145 |
| QOL Medical, LLC | 6 | $136 |
| Neurocrine Biosciences, Inc. | 5 | $136 |
| Pfizer | 7 | $129 |
| Gilead | 1 | $123 |
| Acadia Pharmaceuticals Inc | 3 | $82 |
| Mirum Pharmaceuticals, Inc. | 3 | $77 |
| Kyowa Kirin, Inc. | 4 | $74 |
| Azurity Pharmaceuticals, Inc. | 3 | $60 |
| Travere Therapeutics, Inc. | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Neurelis, Inc. | 3 | $53 |
| Soleno Therapeutics, Inc. | 1 | $32 |
| RARE Disease Therapeutics, Inc. | 1 | $30 |
| Biomarin Pharmaceutical Inc. | 1 | $27 |
| Alcresta Therapeutics, Inc. | 2 | $26 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Albireo Pharma, Inc. | 1 | $22 |
| Tolmar, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Immedica Pharma US, Inc. | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| ERBE USA Inc | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Cranial Technologies, Inc | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,078 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.
Other pediatrics in Madera
- Steven EhrreichMadera$59K
- Laurene MascolaLos Angeles$451K
- Tonya ChaffeeSan Francisco$359K
- Anthony PortaleSan Francisco$354K
- David KesslerSan Francisco$335K
- Lawrence SherRolling Hills Estates$297K
- Steven BlackOakland$228K
- Jonathan StroberSan Francisco$164K
- Hasmukh AminBakersfield$140K
- Colleen KraftNewport Beach$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.